Researchers studied patients with stage 0 to III breast cancer who were treated with breast-conserving therapy and received APBIb treatment. They assessed whether these patients were categorized as suitable, cautionary or unsuitable based on a consensus statement by ASTRO Health Services Research Committee. Results showed that of the patients treated with APBIb, 32 percent were suitable, 30 percent were cautionary and 36 percent were unsuitable.
However, the fastest increase in utilization was among patients who were classified as suitable.
Related Articles on Overuse of Healthcare Services:
Medical Societies, ABIM Foundation Campaign Targets Overused Healthcare Services
Joint Commission Proposes Patient Safety Goal to Reduce Overuse of Healthcare Services
Data Shows Many Hospitals Overuse Double CT Scans
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
